Category : Search result: medication myths


Trump: Deal Reached to Lower Weight Loss Drug Prices

Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.

White House Deal Cuts Ozempic & Wegovy Prices in India

In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.

Obesity Drugs: Not Miracle Cures

Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.

Novo Nordisk Profit Drops 27%, Cuts 9,000 Jobs

Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.

Trump's $149 Weight-Loss Drug Deal with Ozempic Maker

Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.

Common Women's Drug Increases Breast Cancer Risk: Study

Groundbreaking research reveals a startling connection between a medication used by millions of women worldwide and increased breast cancer risk. Discover what the study found and how it could impact women's health decisions.

Atorvastatin Recall: Cholesterol Drug Safety Alert

Critical drug recall affects millions of Indians taking Atorvastatin. Learn about the safety concerns, batch numbers, and what immediate steps you should take if you're on cholesterol medication.

FDA Approves Oral Weight Loss Drug Rybelsus

Breaking news: US FDA approves Rybelsus, the groundbreaking oral weight loss medication that mimics popular injection drugs. Discover how this pill could revolutionise obesity treatment in India and worldwide.

FDA Recalls 580K Blood Pressure Meds Over Cancer Risk

Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.

Tylenol During Pregnancy: US Urges Caution

US Health Secretary Xavier Becerra advises pregnant women to consult doctors before using Tylenol, citing insufficient data to confirm autism link but recommending precautionary approach.

Hepatitis A: Busting 7 Dangerous Myths for Parents

Is your child safe from Hepatitis A? Discover the shocking truths behind common misconceptions about this liver infection that's spreading across India. Expert-backed facts to protect your family.

Mammogram Myths: 4 False Beliefs Risking Health

Are outdated myths preventing you from getting life-saving breast cancer screening? Experts reveal the truth about mammograms and why delaying could be dangerous for Indian women.

3 Meds That Cause Dangerous Sodium Drop

Leading neurologist reveals how everyday medicines for depression, pain, and blood pressure can cause life-threatening hyponatremia. Learn the warning signs and protect yourself.

Semaglutide Boosts Heart Health in New Study

Groundbreaking research from Pune reveals diabetes drug semaglutide significantly reduces cardiovascular risks in non-diabetic patients, offering dual benefits for weight and heart health.

FDA Recalls 140K+ Cholesterol Drug Bottles

Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.

Eli Lilly-Cipla Partner for Weight Loss Drugs in India

Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.

Page 1 of 2